Evidence map

TrialDiabetes, obesity & metabolism2021

Efficacy and safety of liraglutide in type 1 diabetes by baseline characteristics in the ADJUNCT ONE and ADJUNCT TWO randomized controlled trials.

Thomas F Dejgaard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

27 papers cite it

2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 34463425